ArticleAvicenna journal of medicine2014
The first linezolid-resistant Enterococcus faecium in India: High level resistance in a patient with no previous antibiotic exposure.
Article in Avicenna journal of medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 25 citations in OpenAlex.
- Molecular Detection of Linezolid Resistance Determinants and Identification of a Novel C2626T Mutation in Clinical Isolates ofAntibiotics (Basel, Switzerland) · 2026Article
- Linezolid-resistant Enterococcus faecium clinical isolates from Pakistan: a genomic analysis.BMC microbiology · 2024Article
- Relationship Between COVID-19 and Linezolid-Resistant Enterococci: A Retrospective Single-Center Study.Cureus · 2024Article
- Vancomycin and Linezolid-Resistant Enterococcus Isolates from a Tertiary Care Center in India.Diagnostics (Basel, Switzerland) · 2023Article
- The Prevalence and Antimicrobial Susceptibility Pattern of Gram-Positive Pathogens: Three-Year Study at a Tertiary Care Hospital in Mumbai, India.Journal of laboratory physicians · 2022Article
- Biofilm ProducingAntibiotics (Basel, Switzerland) · 2021Article
- Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.The Journal of antimicrobial chemotherapy · 2019Article
- Linezolid-resistantJournal of family medicine and primary care · 2019Article
- Linezolid and Vancomycin Resistant Enterococci: A Therapeutic Problem.Journal of clinical and diagnostic research : JCDR · 2017Article
- Article
- Linezolid-resistantJournal of global infectious diseasesArticle
- Microbiological profile and antibiotic susceptibility pattern of Gram-positive isolates at a tertiary care hospital.Journal of laboratory physiciansArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Linezolid provides high rates of the clinical cure and microbiological success in complicated infections due to Enterococcus spp., including vancomycin-resistant Enterococcus faecium. However, the emergence of resistance during linezolid treatment has been reported for clinical strains of Enterococcus, which is alarming given the fact that, this leaves the clinician with very few treatment options. We report the first case of linezolid resistant Enterococcus faecium from India, which was isolated from the blood culture of a hypoglycemic encephalopathy patient. There have been previous reports of linezolid resistant enterococci from different parts of the world, with minimum inhibitory concentration (MIC) ranging from 16 to 64 μg/mL and most of them were associated with vancomycin resistance but the isolate reported over here had an MIC of 1024 μg/mL and interestingly was sensitive to vancomycin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.